Great Lakes Advisors LLC Has $10.54 Million Position in Linde PLC $LIN

Great Lakes Advisors LLC lessened its stake in shares of Linde PLC (NASDAQ:LINFree Report) by 14.3% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 22,187 shares of the basic materials company’s stock after selling 3,690 shares during the period. Great Lakes Advisors LLC’s holdings in Linde were worth $10,539,000 at the end of the most recent reporting period.

Other institutional investors have also recently modified their holdings of the company. Darwin Wealth Management LLC acquired a new stake in shares of Linde during the 2nd quarter worth $25,000. Marquette Asset Management LLC bought a new stake in Linde during the third quarter worth about $27,000. YANKCOM Partnership grew its stake in Linde by 195.2% during the third quarter. YANKCOM Partnership now owns 62 shares of the basic materials company’s stock worth $29,000 after buying an additional 41 shares in the last quarter. Albion Financial Group UT increased its holdings in Linde by 87.8% in the 3rd quarter. Albion Financial Group UT now owns 77 shares of the basic materials company’s stock valued at $37,000 after buying an additional 36 shares during the period. Finally, Howard Hughes Medical Institute bought a new position in Linde in the 2nd quarter valued at about $48,000. 82.80% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of analysts have recently weighed in on the stock. BMO Capital Markets set a $501.00 price target on shares of Linde in a report on Wednesday, December 17th. Mizuho set a $495.00 price objective on shares of Linde in a research report on Thursday, December 11th. Sanford C. Bernstein restated an “outperform” rating and set a $516.00 target price on shares of Linde in a research note on Monday, November 3rd. CICC Research began coverage on Linde in a research note on Wednesday, December 3rd. They issued an “outperform” rating and a $510.00 price target on the stock. Finally, JPMorgan Chase & Co. lowered their price target on Linde from $475.00 to $455.00 and set an “overweight” rating for the company in a report on Monday, November 3rd. One investment analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average target price of $501.75.

Get Our Latest Stock Report on LIN

Linde Stock Up 0.8%

Shares of NASDAQ:LIN opened at $455.00 on Friday. Linde PLC has a 52-week low of $387.78 and a 52-week high of $486.38. The company has a market capitalization of $212.46 billion, a PE ratio of 30.48, a price-to-earnings-growth ratio of 3.17 and a beta of 0.85. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.69 and a current ratio of 0.82. The company has a fifty day moving average of $424.93 and a 200-day moving average of $447.99.

Linde (NASDAQ:LINGet Free Report) last issued its quarterly earnings data on Friday, October 31st. The basic materials company reported $4.21 earnings per share for the quarter, topping analysts’ consensus estimates of $4.18 by $0.03. Linde had a return on equity of 19.38% and a net margin of 21.17%.The business had revenue of $8.62 billion for the quarter, compared to analyst estimates of $8.62 billion. During the same quarter in the previous year, the company posted $3.94 EPS. Linde’s quarterly revenue was up 2.9% compared to the same quarter last year. On average, equities analysts predict that Linde PLC will post 16.54 EPS for the current fiscal year.

About Linde

(Free Report)

Linde (NASDAQ: LIN) is a multinational industrial gases and engineering company that supplies gases, related technologies and services to a wide range of industries. The company traces its current form to the 2018 combination of Germany’s Linde AG and U.S.-based Praxair, creating one of the largest global providers of industrial, specialty and medical gases. Linde’s business model centers on production, processing and distribution of gases as well as the design and construction of the plants and equipment needed to produce them.

Core products and services include atmospheric and process gases such as oxygen, nitrogen and argon; hydrogen and helium; carbon dioxide; and a portfolio of higher‑value specialty and electronic gases.

Featured Stories

Institutional Ownership by Quarter for Linde (NASDAQ:LIN)

Receive News & Ratings for Linde Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Linde and related companies with MarketBeat.com's FREE daily email newsletter.